Seguir
Nicola Margiotta
Nicola Margiotta
Dirección de correo verificada de uniba.it
Título
Citado por
Citado por
Año
Biomimetic hydroxyapatite–drug nanocrystals as potential bone substitutes with antitumor drug delivery properties
B Palazzo, M Iafisco, M Laforgia, N Margiotta, G Natile, CL Bianchi, ...
Advanced Functional Materials 17 (13), 2180-2188, 2007
4092007
Smart delivery of antitumoral platinum complexes from biomimetic hydroxyapatite nanocrystals
M Iafisco, B Palazzo, M Marchetti, N Margiotta, R Ostuni, G Natile, ...
Journal of Materials Chemistry 19 (44), 8385-8392, 2009
1082009
Revisiting [PtCl2(cis-1,4-DACH)]: An Underestimated Antitumor Drug with Potential Application to the Treatment of Oxaliplatin-Refractory Colorectal Cancer
N Margiotta, C Marzano, V Gandin, D Osella, M Ravera, E Gabano, ...
Journal of medicinal chemistry 55 (16), 7182-7192, 2012
812012
Nanocrystalline carbonate-apatites: role of Ca/P ratio on the upload and release of anticancer platinum bisphosphonates
M Iafisco, B Palazzo, G Martra, N Margiotta, S Piccinonna, G Natile, ...
Nanoscale 4 (1), 206-217, 2012
772012
Platinum (II) complexes with bioactive carrier ligands having high affinity for the translocator protein
N Margiotta, N Denora, R Ostuni, V Laquintana, A Anderson, SW Johnson, ...
Journal of medicinal chemistry 53 (14), 5144-5154, 2010
752010
Silica xerogels and hydroxyapatite nanocrystals for the local delivery of platinum–bisphosphonate complexes in the treatment of bone tumors: A mini-review
M Iafisco, N Margiotta
Journal of inorganic biochemistry 117, 237-247, 2012
662012
Cytotoxicity, cellular uptake, glutathione and DNA interactions of an antitumor large-ring PtII chelate complex incorporating the cis-1, 4-diaminocyclohexane carrier ligand
J Kasparkova, T Suchankova, A Halamikova, L Zerzankova, O Vrana, ...
Biochemical pharmacology 79 (4), 552-564, 2010
602010
Insights into the role of the lead/surfactant ratio in the formation and passivation of cesium lead bromide perovskite nanocrystals
R Grisorio, E Fanizza, I Allegretta, D Altamura, M Striccoli, R Terzano, ...
Nanoscale 12 (2), 623-637, 2020
532020
Conformer Distribution in (cis-1,4-DACH)bis(guanosine-5′-phosphate)platinum(II) Adducts: A Reliable Model for DNA Adducts of Antitumoral Cisplatin
R Ranaldo, N Margiotta, FP Intini, C Pacifico, G Natile
Inorganic chemistry 47 (7), 2820-2830, 2008
512008
Platinum (II) complexes with antitumoral/antiviral aromatic heterocycles: Effect of glutathione upon in vitro cell growth inhibition
P Papadia, N Margiotta, A Bergamo, G Sava, G Natile
Journal of medicinal chemistry 48 (9), 3364-3371, 2005
502005
Synthesis and characterization of a platinum (II) complex tethered to a ligand of the peripheral benzodiazepine receptor
N Margiotta, R Ostuni, R Ranaldo, N Denora, V Laquintana, G Trapani, ...
Journal of medicinal chemistry 50 (5), 1019-1027, 2007
482007
PEGylated solid lipid nanoparticles for brain delivery of lipophilic kiteplatin Pt (IV) prodrugs: An in vitro study
I Arduino, N Depalo, F Re, R Dal Magro, A Panniello, N Margiotta, ...
International journal of pharmaceutics 583, 119351, 2020
442020
Strong, rapid binding of a platinum complex to thymine and uracil under physiological conditions
N Margiotta, A Habtemariam, PJ Sadler
Angewandte Chemie International Edition in English 36 (11), 1185-1187, 1997
421997
A new dinuclear platinum complex with a nitrogen-containing geminal bisphosphonate as potential anticancer compound specifically targeted to bone tissues
N Margiotta, F Capitelli, R Ostuni, G Natile
Journal of inorganic biochemistry 102 (12), 2078-2086, 2008
412008
Sterically hindered complexes of platinum (II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from …
N Margiotta, G Natile, F Capitelli, FP Fanizzi, A Boccarelli, P De Rinaldis, ...
Journal of inorganic biochemistry 100 (11), 1849-1857, 2006
412006
Platinum-based antitumor drugs containing enantiomerically pure α-trifluoromethyl alanine as ligand
N Margiotta, P Papadia, F Lazzaro, M Crucianelli, F De Angelis, C Pisano, ...
Journal of medicinal chemistry 48 (24), 7821-7828, 2005
412005
Bisphosphonate‐functionalized imaging agents, anti‐tumor agents and nanocarriers for treatment of bone cancer
RA Nadar, N Margiotta, M Iafisco, JJJP van den Beucken, OC Boerman, ...
Advanced healthcare materials 6 (8), 1601119, 2017
402017
Bisphosphonate complexation and calcium doping in silica xerogels as a combined strategy for local and controlled release of active platinum antitumor compounds
N Margiotta, R Ostuni, D Teoli, M Morpurgo, N Realdon, B Palazzo, ...
Dalton Transactions, 3131-3139, 2007
392007
Antiviral properties and cytotoxic activity of platinum (II) complexes with 1, 10-phenanthrolines and acyclovir or penciclovir
N Margiotta, A Bergamo, G Sava, G Padovano, E De Clercq, G Natile
Journal of inorganic biochemistry 98 (8), 1385-1390, 2004
392004
Synthesis, characterization, and in vitro cytotoxicity of a Kiteplatin-Ibuprofen Pt (IV) prodrug
A Curci, N Denora, RM Iacobazzi, N Ditaranto, JD Hoeschele, N Margiotta, ...
Inorganica Chimica Acta 472, 221-228, 2018
382018
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20